Clinical significance of immunocytochemical staining for peritoneal lavage cytology in pancreatic cancer
Author:
Kubo HidemasaORCID,
Ohgi KatsuhisaORCID,
Ohike Nobuyuki,
Tone Kiyoshi,
Norose Tomoko,
Sugiura Teiichi,
Ashida Ryo,
Yamada Mihoko,
Otsuka Shimpei,
Uesaka KatsuhikoORCID
Reference25 articles.
1. Cancer statistics, 2021;Siegel;CA Cancer J Clin,2021
2. Adjuvant and neoadjuvant treatment for pancreatic adenocarcinoma;Motoi;Jpn J Clin Oncol,2020
3. Oncological benefits of neoadjuvant chemoradiation with gemcitabine versus upfront surgery in patients with borderline resectable pancreatic cancer: a prospective, randomized, open-label, multicenter phase 2/3 trial;Jang;Ann Surg,2018
4. Adjuvant chemotherapy of s-1 versus gemcitabine for resected pancreatic cancer: a phase 3, open-label, randomised, non-inferiority trial (JASPAC 01);Uesaka;Lancet,2016
5. Prognostic importance of peritoneal washing cytology in patients with otherwise resectable pancreatic ductal adenocarcinoma who underwent pancreatectomy: a nationwide, cancer registry-based study from the Japan Pancreas Society;Tsuchida;Surgery,2019
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献